Ohio State Navbar

Study Dings Reflux Drugs for Kids’ Asthma

Columbus Dispatch
Acid-reflux medications appear to do more harm than good when prescribed to certain children with asthma, according to a new study. Researchers found that lansoprazole, which sells under several brand names, including Prevacid, increased the risk of respiratory infections and did not improve asthma control in children who didn’t have reflux symptoms. “This should change practice,” said Dr. John Mastronarde, director of Ohio State University’s asthma center and one of the authors of the study, which was published in The Journal of the American Medical Association and supported by the American Lung Association and the National Institutes of Health. This coverage resulted from pitching efforts by OSU Medical Center Public Affairs and Media Relations.

Columbus Dispatch article